DefiniGEN / Wellcome Trust / Anne McLaren Laboratory / Ed Cartwright Amantys / GlaxoSmithKline / ARM plc. / Amantys / /
Country
United Kingdom / /
Currency
GBP / USD / /
Facility
Anne McLaren Laboratory of Regenerative Medicine / Sanger Institute / University of Cambridge / Cambridge University / Cambridge Institute / Gurdon Institute / University of Cambridge The / Rosie Hospital / /
IndustryTerm
renewable and non-renewable energy sources / healthcare-associated infections / semiconductor devices / real time bacterial spread / translational funding applications / start-up / power electronics / technology transfer services / power electronics sector / pharmaceutical / healthcare / potential therapeutic applications / productive technology clusters / therapy for emphysema / energy / power electrical equipment / priority applications / consultancy services / research / power electronics industry / food security / electronic devices / electronic switching products / energy sector / seed fund services / energy efficiency / energy output / gate driver products / /
Argenta / Special Care Baby Unit / Cambridge University / Department of Engineering / Cambridge Institute for Medical Research / Rosie Hospital / Department of Pharmacology / Sanger Institute / University of Cambridge / Gurdon Institute / Department of Health / Department of Anaesthesia / /
Person
Roger Pedersen / Pete Magowan / Nick Hannan / Ludovic Vallier / Ludovic Vallier Rosettes / Lynn Gladden / Mark Snook / Peter McNaughton / Tony Raven / Bryn Parry / David Lomas / Tamir Rashid / Patrick Palmer / Sharon Peacock / Candy Cho / /
Position
driver / Chief Executive / Pro-Vice-Chancellor / CEO / leader / Professor / /
Product
InsightTM / OptiDIFF platform / OptiDIFF / /
Technology
Alpha / semiconductor devices / transplantation / stem cells / Drug Discovery / regenerative medicine / /
Annual Review 2012 From the Pro-Vice-Chancellor (Research) From the Chief Executive